4th Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for AMGEN USA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues related to pharmaceutical patents.

LobbyistCovered position, as disclosed
CASEY CHRISTINE HIGGINS New Asst to Spkr for Policy and Trade Cnsl, Paul Ryan, Nov 15-Jan 19; Trade Cncl to House Ways & Means, Jan 15-Nov 15; LC to Rep. Paul Ryan, Oct 11-Jan 15; Law Clrk House Budget Comm, Sep 09-May 10.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Drug pricing issues, including the IPI Drug Pricing Model, Prescription Drug Pricing Act (S. 2543), the Lower Costs, More Cures Act (S. 3129) and other congressional proposals.

LobbyistCovered position, as disclosed
GORDON HUNTER BATES —
RYAN ELLIS New —
LAUREN B O'BRIEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2543 (116th), S. 3129 (116th)

Trade (domestic/foreign) TRD

Support for biologics data exclusivity period in USMCA.

LobbyistCovered position, as disclosed
LAUREN B O'BRIEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.